drugset / Trial / NCT00753493

Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients

NCT00753493

Phase 1 Completed 20 enrolled University of Minnesota
NaSingle-groupOpen-labelTreatment

Summary

The aims of this study are to determine, in adult patients on maintenance topiramate therapy, the steady-state pharmacokinetics and safety of orally and intravenously administered topiramate.

Timeline

Start
2008-08
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 25 mg Intravenous